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Abstract
Levels of activity are often affected in psychiatric disorders and can be core symptoms of ill-
ness. Advances in technology now allow the accurate assessment of activity levels but it
remains unclear whether alterations in activity arise from shared risk factors for developing
psychiatric disorders, such as genetics, or are better explained as consequences of the dis-
orders and their associated factors. We aimed to examine objectively-measured physical
activity in individuals with psychiatric disorders, and assess the role of genetic liability for
psychiatric disorders on physical activity. Accelerometer data were available on 95,529 UK
Biobank participants, including measures of overall mean activity and minutes per day of
moderate activity, walking, sedentary activity, and sleep. Linear regressions measured
associations between psychiatric diagnosis and activity levels, and polygenic risk scores
(PRS) for psychiatric disorders and activity levels. Genetic correlations were calculated
between psychiatric disorders and different types of activity. Having a diagnosis of schizo-
phrenia, bipolar disorder, depression, or autism spectrum disorders (ASD) was associated
with reduced overall activity compared to unaffected controls. In individuals without a psy-
chiatric disorder, reduced overall activity levels were associated with PRS for schizophrenia,
depression, and ASD. ADHD PRS was associated with increased overall activity. Genetic
correlations were consistent with PRS findings. Variation in physical activity is an important
feature across psychiatric disorders. Whilst levels of activity are associated with genetic lia-
bility to psychiatric disorders to a very limited extent, the substantial differences in activity
levels in those with psychiatric disorders most likely arise as a consequences of disorder-
related factors.
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Introduction
Estimates suggest that physical inactivity causes 9% of premature mortality and 6–10% of the
major non-communicable diseases worldwide [1]. Research consistently shows that individu-
als who engage in less physical activity report more stress [2], perform worse on cognitive
tasks [3], are more likely to become depressed [4, 5], and are at increased risk of cardiovascular
disease, cancer, hypertension and diabetes [6]. Physical activity can be a core indicator of men-
tal illness, from the increased activity seen in attention deficit hyperactivity disorder (ADHD)
and mania to the decreased activity seen in depression and as part of the negative symptoms of
schizophrenia [7–10]. Understanding the factors contributing to physical activity may assist in
improving mental health, as well as reducing risk of chronic physical health conditions, many
of which are known to be increased in individuals with severe mental illness [11].
Studies of physical activity have predominantly relied on self-report measures but this may
lead to unreliable estimates of activity, especially for those with mental illness. A recent study
reported marked differences when comparing accelerometer-measured activity between indi-
viduals with schizophrenia and controls, but not for self-reported activity [12]. This suggests
that objective measures may better characterise physical activity in individuals with mental
health disorders, and such approaches are being considered as part of clinical psychiatric care
[13]. Research using accelerometers in the UK Biobank has shown physical activity to be a
polygenic trait, with a heritability of around 23% in women and 20% in men [14].
Physical activity in those with psychiatric disorders may be influenced by genetic liability to
activity in the wider population, although it may primarily reflect disorder-specific factors.
Conversely, it is possible that genetic liability for psychiatric disorders influences physical
activity, rather than activity differences being a consequence of the illness. Other factors
known to be associated with both psychiatric disorders and physical activity, such as smoking,
obesity, and social deprivation [15–17], may also confound this relationship and thus require
investigation.
A small number of studies have applied Mendelian Randomisation (MR) methodology [18]
to examine the hypothesis that low physical activity might be a risk factor for developing psy-
chiatric disorders, particularly depression and schizophrenia [19, 20]. Some have reported
findings consistent with the hypothesis that low physical activity might be causally related to
depression, although one of the limitations of such studies is the lack of robust genetic instru-
ments for MR analyses. Currently, the relationship between genetic liability to physical activity
and psychiatric disorders is unclear.
We aimed to assess the levels of objectively-measured physical activity in individuals with
psychiatric disorders, and establish whether genetic liability for psychiatric disorders is associ-
ated with levels of physical activity in a population sample. We hypothesised that objective lev-
els of physical activity in individuals with mental health disorders would differ from
individuals without, and that there would be an association between polygenic risk for psychi-
atric disorders and level of physical activity in individuals without mental health disorders.
Method
Participants
Study participants were from the population-based UK Biobank sample, a national cohort
study of over 500,000 individuals aged 40–69 at the time of recruitment from one of 22 assess-
ment centres across the UK between 2006–2010 [21]. Between 2013 and 2015, a subset of indi-
viduals was invited to participate in a study of device-measured physical activity (see S1 Fig for
timeline of data collection). A random group of participants with a valid email address were
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invited, with the exception of those residing in the North West region, who were excluded due
to concerns over participant burden. Of the 236,519 individuals approached, 106,053 con-
sented to participate [22]. Our study was conducted as part of UK Biobank project number
13310. Ethical approval for UK Biobank was granted by the North West Multi-Centre Ethics
Committee and all participants provided written informed consent. All procedures contribut-
ing to this work comply with the ethical standards of the relevant national and institutional
committees on human experimentation and with the Helsinki Declaration of 1975, as revised
in 2008.
Psychiatric diagnosis
A diagnosis of schizophrenia, bipolar disorder, depression, ADHD, or an autism spectrum dis-
order (ASD) was defined from (i) self-report at the initial assessment, (ii) the mental health
questionnaire [23] (Field ID: 20544), (iii) a diagnosis recorded on a hospital record, or (iv) a
diagnosis recorded on a death record. Where individuals reported multiple diagnoses, they
were included in each appropriate diagnostic group. For hospital and death records, partici-
pants were deemed to have a diagnosis when the following ICD-10 codes were present: F20 for
schizophrenia, F30 or F31 for bipolar disorder, F32 or F33 for depression, F84 for ASD, and
F90 for ADHD. We selected these disorders as altered activity can be a prominent feature of
the disorder and substantial GWAS data exist to allow us to test genetic hypotheses.
Genetic data
Genetic data were made available through UK Biobank, following imputation and quality con-
trol procedures that have been described elsewhere [24]. Participants were assayed at the Affy-
metrix Research Services laboratory using the UK Biobank Axiom or UK BiLEVE Axiom
purpose-built arrays and imputation was performed using the Haplotype Reference Consor-
tium panel [25]. Subsequent to imputation, we applied further quality control filters to select
high-quality SNPs: minor allele frequency > 0.01, imputation score> 0.8, missingness < 0.05,
and Hardy-Weinberg equilibrium p-value> 1x10-6. All genetic analyses were restricted to par-
ticipants of European ancestry, confirmed through self-reported data and principal compo-
nents [24] (UK Biobank Field IDs: 21000, 22009) as described in a previous study [26], and
related individuals with a kinship score greater than 0.125 were removed at random.
Genetic correlations
We measured genetic correlations to examine the relationships between psychiatric disorder
genetic risk and five classes of activity: overall, moderate, walking, sedentary, and sleep dura-
tion. We used Linkage Disequilibrium (LD) score regression [27, 28] to calculate genetic corre-
lations between each activity class and schizophrenia [29], bipolar disorder [30], major
depressive disorder (MDD) [31], ADHD [32], and ASD [33].
Polygenic risk scores
PRSice [34] was used to derive polygenic risk scores (PRS) for schizophrenia, bipolar disorder,
MDD, ADHD, and ASD from the same external discovery datasets used for the genetic corre-
lations, following the methods used by the Psychiatric Genomics Consortium (PGC) [26, 35].
PRS were calculated at six thresholds: p<5x10-8, 5x10-6, 5x10-4, 0.05, 0.1, 0.5. PRS were then
standardised as Z-scores for each disorder, to allow for comparison between disorders.
PLOS ONE Physical activity and psychiatric disorders
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Accelerometer-measured physical activity
Participants wore an Axivity AX3 tri-axial accelerometer for one week on the wrist of their
dominant hand. The accelerometer captures activity at 100Hz with a dynamic range of ±8g.
Data were processed by the accelerometer working group [22] in line with standard protocols,
including calibration of devices, low-pass filtering to remove high frequency noise, and identi-
fication of non-wear periods [22, 36–38]. A measure of overall physical activity was computed
by partitioning the data into five second epochs and calculating the mean vector magnitude of
each epoch to derive an overall mean acceleration (UK Biobank Field ID: 90012).
We also used derived measures of time spent in sleep and physical activity behaviours. A
recent study by Doherty et al. [14] classified the accelerometer activity being undertaken as
sedentary, walking, moderate, or sleeping. In this study, participants in an independent sample
wore wrist-worn accelerometers and a wearable camera for one week, in order to map the
accelerometer readings to an observable activity. Machine learning methods were then used to
create a model that was able to classify accelerometer readings into a pre-defined type of activ-
ity [14]. The researchers used these data to derive an overall probability of each participant
engaging in each type of activity at any given time (Return ID: 1942). Overall level activity was
standardised as a Z-score; moderate, walking, sedentary, and sleep were converted into min-
utes spent per day engaging in the activity type. Individuals with insufficient device wear time,
poor device calibration and an overall mean activity Z score greater than 3 were excluded from
analysis.
Doherty et al. [14] conducted a GWAS on each of the activity subtypes; we used the sum-
mary statistics from these GWAS for LD score regression.
Analysis
All analyses were corrected for multiple comparisons using false discovery rate (FDR) at
p<0.05.
Linear regressions were conducted to measure the effect of diagnosis of schizophrenia,
bipolar disorder, depression, ADHD and ASD on all types of activity: overall, moderate, walk-
ing, sedentary and sleep. Age, sex, and BMI were included as covariates in all models.
Linear regressions were used to measure the associations between each disorder PRS and
each type of activity, with age, sex, BMI, and genotyping array included as covariates in all PRS
models. We routinely included the first five principal components as covariates. We also
examined 20 principal components for each type of activity, and included any that were signif-
icantly associated with the relevant activity. This varied for each test and ranged from one
additional component for overall activity, to three additional components each for moderate
and sedentary activity.
PRS associations were conducted at the p< .05 threshold for the primary analyses; the
remaining five thresholds were also tested for robustness. Individuals with a psychotic disor-
der, bipolar disorder, depression, ADHD or ASD diagnosis were excluded from all PRS analy-
ses, leaving a total of 76,409 participants. None of the genome-wide association study (GWAS)
discovery datasets we have used included the UK Biobank as a sample, but we are unable to
definitively exclude an incidental degree of sample overlap. We note however that as calculated
here, genetic correlations derived from LD-score regression are robust to sample overlaps [28].
Moreover, all of the intercepts for our genetic correlations are below one, which is consistent
with minimal sample overlap between the discovery GWAS and the target sample for PRS.
In order to assess whether the relationship between PRS for psychiatric disorders and physi-
cal activity could be influenced by other confounders, we added alcohol use (Field ID: 20414),
cannabis use (Field ID: 20453), substance or behavioural addiction (Field ID: 20401), smoking
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status (Field ID: 20116), fluid intelligence (Field ID: 20016), and Townsend deprivation index
(Field ID: 189) as additional covariates in the overall levels of activity PRS models. These data
were available on 15,285 participants who had also completed the mental health questionnaire.
To assess whether including BMI as a covariate could be a source of collider bias, we
repeated the diagnosis and PRS analyses with BMI excluded from the model.
Results
Age, sex, and diagnosis were available on 236,502 individuals who were invited to participate
in the accelerometer study. Participation in the accelerometer study was significantly, yet mini-
mally, associated with age at recruitment (OR = 1.002; 95% CI = 1.001, 1.003; p = 2.7x10-6), as
well as with female sex (OR = 1.14; 95% CI = 1.13, 1.16; p = 4.7x10-59). Individuals with a diag-
nosis of schizophrenia, bipolar disorder, depression, ADHD, or ASD were significantly less
likely to participate than individuals without a mental health disorder (OR = 0.95; 95%
CI = 0.92, 0.98; p = 0.002).
A total of 95,744 participants were included in the study with high quality accelerometer
data (56.4% female, mean age at recruitment [SD] 56.2 [7.8], see S2 Fig). 6,527 individuals
were classified as having depression, 466 with bipolar disorder, 95 with schizophrenia, 87 with
ASD, and 53 with ADHD.
Activity levels in psychiatric disorders
Results are presented in Table 1, Figs 1 and 2. After correcting for multiple comparisons,
schizophrenia was associated with reduced levels of overall activity, reduced time spent in
moderate activity and longer sleep duration. Bipolar disorder was associated with reduced lev-
els of overall activity, reduced time spent in moderate activity and walking, and longer sleep
duration. Depression was associated with reduced levels of overall activity, reduced time spent
in moderate activity and walking, and longer sleep duration. ASD was associated with reduced
levels of overall activity, reduced time spent walking, and increased time spent in sedentary
activity. ADHD was not associated with changes in any type of activity.
Genetic correlations. Schizophrenia was genetically correlated with more time spent
walking (rg = 0.11, p = 0.01), reduced time spent in a sedentary activity (rg = -0.09, p = 0.02),
and longer sleep duration (rg = 0.07, p = 0.04). Bipolar disorder was genetically correlated with
greater moderate activity (rg = 0.22, p = 4x10-3) and more time spent walking (rg = 0.11,
p = 0.05). MDD was genetically correlated with reduced overall activity (rg = -0.1, p = 0.01)
and reduced walking (rg = -0.1, p = 0.02). ASD was significantly genetically correlated with
greater sedentary activity (rg = 0.25, p = 3x10-3) and reduced sleep duration (rg = -0.2, p = 0.01).
Regression coefficients for all comparisons are displayed in Fig 3 and full results are presented
in S1 Table.
Polygenic risk scores
Results are presented in Table 1, Figs 1 and 2. In individuals without a mental health disorder,
after correcting for multiple comparisons, schizophrenia PRS was associated with reduced lev-
els of overall activity, increased time spent in moderate activity, increased time spent walking,
reduced time spent in sedentary activity, and longer sleep duration. Bipolar disorder PRS was
associated with increased time spent in moderate activity, increased time spent walking, and
reduced time spent in sedentary activity. MDD PRS was associated with reduced levels of over-
all activity, reduced time spent in moderate activity, reduced time spent walking, and longer
sleep duration. ADHD PRS was associated with increased levels of overall activity, increased
time spent in moderate activity, reduced time spent in sedentary activity, and longer sleep
PLOS ONE Physical activity and psychiatric disorders
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duration. ASD PRS was associated with reduced levels of overall activity, reduced time spent
walking, increased time spent in sedentary activity, and shorter duration of sleep.
PRS associations were consistent across the thresholds tested (S2–S6 Tables). The proportion
of variance explained by PRS for each type of activity are demonstrated in S3 Fig. The effect sizes
for schizophrenia, bipolar disorder, and ADHD PRS in association with overall levels of activity
remained consistent after covarying for alcohol use, cannabis use, substance or behavioural addic-
tion, smoking status, fluid intelligence, and Townsend deprivation index. However, effect sizes
were reduced for MDD and ASD PRS when these covariates were included (S7 Table). Results
were consistent between models that included and excluded BMI as a covariate (S8 Table).
Discussion
In this study, we found levels of objectively-measured physical activity to be altered in UK Bio-
bank participants with a diagnosis of schizophrenia, bipolar disorder, depression, or ASD. We
observed several significant genetic correlations between psychiatric disorders and types of
activity, suggesting that the genetic architecture of physical activity is shared, to a small extent,
with the genetic architecture of psychiatric disorders. Increased PRS for schizophrenia, bipolar
Table 1. Association between activity and both psychiatric disorders and polygenic risk scores for psychiatric disorders in the UK Biobank.
Disorder Activity Psychiatric disorder Polygenic risk score
Beta (95% CI) P-value Beta (95% CI) P-value
Schizophrenia Overall -0.4 (-0.5, -0.2) 9.3x10-5 -0.01 (-0.01, -0.002) 0.01
Moderate -14.8 (-25.1, -4.4) 0.01 0.4 (0.03, 0.8) 0.04
Walking -5.8 (-18.5, 7.0) 0.50 1.0 (0.5, 1.5) 9.6x10-5
Sedentary -14.3 (-34.7, 6.1) 0.25 -1.2 (-2.0, -0.5) 3.0x10-3
Sleep 42.2 (27.1, 57.3) 1.9x10-7 0.8 (0.3, 1.3) 0.01
Bipolar disorder Overall -0.3 (-0.4, -0.2) 2.5x10-12 0.002 (-0.004, 0.01) 0.51
Moderate -10.3 (-15.0, -5.7) 4.3x10-5 0.5 (0.1, 0.8) 0.02
Walking -9.5 (-15.2, -3.7) 3.0x10-3 0.7 (0.2, 1.1) 0.01
Sedentary -3.0 (-12.2, 6.3) 0.63 -0.8 (-1.5, -0.1) 0.04
Sleep 22.7 (15.8, 29.5) 4.3x10-10 -0.01 (-0.5, 0.5) 0.96
Depression Overall -0.2 (-0.2, -0.1) 1.5x10-51 -0.02 (-0.02, -0.01) 2.1x10-6
Moderate -1.7 (-3.0, -0.4) 0.02 -0.6 (-0.9, -0.2) 0.01
Walking -11.8 (-13.4, -10.2) 4.0x10-46 -0.8 (-1.2, -0.3) 3.0x10-3
Sedentary 2.6 (0.1, 5.2) 0.07 0.1 (-0.6, 0.8) 0.83
Sleep 11.9 (10.0, 13.8) 8.4x10-34 1.0 (0.4, 1.5) 1.8x10-3
ADHD Overall 0.01 (-0.2, 0.2) 0.97 0.01 (0.003, 0.02) 0.01
Moderate 5.2 (-8.7, 19.1) 0.58 0.6 (0.2, 0.9) 0.01
Walking -4.8 (-21.8, 12.2) 0.66 -0.2 (-0.7, 0.2) 0.39
Sedentary -3.0 (-30.3, 24.3) 0.87 -1.7 (-2.5, -1.0) 1.4x10-5
Sleep -4.0 (-24.3, 16.2) 0.76 0.9 (0.4, 1.4) 3.0x10-3
ASD Overall -0.4 (-0.6, -0.2) 1.8x10-5 -0.01 (-0.01, -0.002) 0.01
Moderate -8.1 (-18.9, 2.7) 0.22 -0.1 (-0.5, 0.2) 0.54
Walking -23.1 (-36.4, -9.9) 1.0x10-3 -0.6 (-1.0, -0.1) 0.02
Sedentary 48.4 (27.1, 69.7) 2.7x10-5 1.9 (1.2, 2.6) 2.5x10-6
Sleep -7.1 (-22.9, 8.7) 0.50 -0.8 (-1.4, -0.3) 0.01
Columns represent the disorder, type of activity, effect size (beta), 95% confidence intervals, and FDR-corrected p-value of the association between either a diagnosis of
the disorder or PRS for the disorder and level of activity. Effect size for overall activity corresponds to standard deviation change in activity, effect sizes for all other types
of activity correspond to minutes per day of activity. We excluded individuals with a psychiatric disorder for PRS analyses.
https://doi.org/10.1371/journal.pone.0249189.t001
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disorder, MDD, ADHD, and ASD were associated with significant, yet minimal, changes in
levels of physical activity in individuals without mental health disorders.
Activity levels in psychiatric disorders
We found that individuals with schizophrenia, bipolar disorder, depression and ASD had
reduced levels of overall physical activity in comparison to individuals without a mental health
diagnosis, consistent with previous research demonstrating reduced levels of subjectively-mea-
sured activity in psychiatric disorders [7–9, 39]. Our results expand upon existing findings by
demonstrating these effects in a sample that is larger than has been reported previously, and by
using objective methods to capture activity. Additionally, we present novel findings that indi-
viduals with psychiatric disorders show different patterns of activity, including reduced mod-
erate activity and longer sleep duration in individuals with schizophrenia, bipolar disorder,
and depression, and increased levels of sedentary activity in individuals with depression and
ASD. Previous research has suggested that disruption to circadian rhythm, measured by
smaller differences between the most active and least active periods of the day, is associated
with increased likelihood of depression and bipolar disorder [39]. Our results support and
extend these findings by demonstrating a reduced pattern of activity with longer sleep duration
in individuals with these disorders. The disruption in physical activity observed in this study
could arise either from disorder-related factors such as symptoms or medication side-effects,
or from risk factors for the disorders. Together these findings suggest that disrupted activity
may be an important aspect of psychiatric illness.
Fig 1. The effect size (beta) for associations between overall activity and diagnoses of, and PRS for, each
psychiatric disorder. Error bars indicate 95% confidence intervals. A beta of 1 is equivalent to a 1 standard deviation
(SD) change in level of activity between individuals with and without a psychiatric disorder or per 1 SD increase in
PRS. We excluded individuals with a psychiatric disorder for PRS analyses.
https://doi.org/10.1371/journal.pone.0249189.g001
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ADHD diagnosis, however, was not associated with level of physical activity. Between 40
and 60% of children with ADHD continue to show symptoms in adulthood [40], thus it is pos-
sible that many participants with an ADHD diagnosis may be asymptomatic by the time of
data collection. Alternatively, our result may reflect the fact that the UK Biobank is a cohort of
individuals aged over 40, who may be less likely to have received a diagnosis of ADHD due to
changes in the awareness of the disorder over time [41].
Genetic liability for psychiatric disorders
In individuals without a mental health disorder, genetic liability for schizophrenia, MDD,
ADHD, and ASD was significantly associated with the overall level of physical activity. We
Fig 2. Associations between type of activity in minutes and diagnoses of, and PRS for, each psychiatric disorder.
Error bars indicate 95% confidence intervals. A beta of 1 is equivalent to a 1 standard deviation (SD) change in level of
activity between individuals with and without a psychiatric disorder or per 1 SD increase in PRS. We excluded
individuals with a psychiatric disorder for PRS analyses.
https://doi.org/10.1371/journal.pone.0249189.g002
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also observed several associations between PRS and levels of subtypes of activity, including
greater levels of moderate activity with increased PRS for schizophrenia, bipolar disorder, and
ADHD. These findings are consistent with the hypothesis that physical activity is one of the
behaviours that is influenced by genetic risk for psychiatric disorders in individuals without
mental health disorders. However, both the estimated effect sizes of PRS associations and the
genetic correlations were small, suggesting that the differences we observed in levels of activity
in individuals with psychiatric disorders are the result of manifesting the disorders per se,
rather than reflections of genetic vulnerability to them. Such factors may be secondary, for
example the use of psychotropic medication [42] or could be symptoms of the disorder itself.
The associations between overall levels of activity and MDD and ASD PRS were attenuated
after controlling for alcohol use, cannabis use, substance addiction, smoking, cognition, and
deprivation, further suggesting that non-genetic factors may have a stronger effect on levels of
activity than PRS. This has important consequences for the physical health of those with psy-
chiatric disorders, particularly as these individuals are known to be at greater risk of numerous
physical health conditions [11] and early mortality [43], which may in part be due to reduced
levels of activity. Further research aiming to understand why physical activity is affected in
psychiatric disorders is necessary to address and improve physical and mental health outcomes
of individuals with these disorders.
Strengths and limitations
We were unable to exclude the possibility of an overlap of participants between training and
target samples when calculating PRS. However, the genetic correlation analysis, for which
non-overlapping samples is not a requirement, supports our PRS findings. Case overlap
between the discovery GWAS and our target sample (UK Biobank) would lead to overestima-
tion of the PRS effect sizes for any PRS associations that are driven by psychiatric diagnoses.
Fig 3. Genetic correlation matrix displaying the correlation coefficient (rg), with square colour indicating
direction of effect. Black text indicates correlation coefficients significant at FDR-corrected p< .05, grey text indicates
non-significant correlations.
https://doi.org/10.1371/journal.pone.0249189.g003
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As the effect sizes we observed are already trivial, any overestimation in effect size would not
in any important way alter the conclusions. A strength of our study is the substantial sample
size, allowing greater power to detect small genetic effects. However, it is important to note
that our sample is a population-based cohort and the limited number of psychiatric cases
within UK Biobank means we were under-powered to measure the influence of genetic risk in
those with psychiatric illness. Individuals with mental health disorders are known to be under-
represented in the UK Biobank and those that are included tend to be a more highly function-
ing group than people with the disorders as a whole [44]. Thus, the differences in levels of
activity in individuals with psychiatric disorders are likely to be underestimated in our study.
Obtaining accelerometer data in a sufficiently-powered sample of individuals with psychiat-
ric disorders is a notable challenge. Nevertheless, future research would benefit from the study
of objectively-measured activity in individuals with mental health disorders, particularly given
findings demonstrating substantial discrepancies between self-report and accelerometer-mea-
sured activity [12].
Conclusions
We found novel evidence of association between schizophrenia, MDD, ADHD, and ASD PRS
and accelerometer-assessed physical activity in the UK Biobank. Levels of physical activity
were significantly reduced in UK Biobank participants with a diagnosis of schizophrenia, bipo-
lar disorder, depression and ASD, emphasising the need for clinical intervention to address
levels of physical activity in these populations. Furthermore, several significant genetic correla-
tions were observed with subtypes of physical activity, most notably between ASD and seden-
tary activity, ASD and sleep duration, and bipolar disorder and moderate activity. Overall, our
findings indicate a weak to modest sharing of liability to the psychiatric disorders and types of
activity we have tested, suggesting that the much more substantial differences in levels of activ-
ity seen in individuals with the psychiatric disorders are mainly consequences of the disorders,
rather than reflections of liability to them.
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